Differences in SLE disease activity between patients of Caucasian and South-East Asian/Chinese background in an Australian hospital

APLAR Journal of Rheumatology

Volumn 9, Issue 1, 2006, Pages 43-48

  Boers, Anthony ^a   Li, Qiang ^a   Wong, Melinda ^a   Miller, Marian ^a   Littlejohn, Geoff ^a  

^a MONASH MEDICAL CENTRE   (Australia)

Author keywords

Caucasian; Flare; Hospitalization; South East Asian; Systemic lupus erythematosus

Indexed keywords

CYCLOPHOSPHAMIDE;

ADULT; ASIAN; AUSTRALIA; CAUCASIAN; CENTRAL NERVOUS SYSTEM DISEASE; CHINESE; CLINICAL OBSERVATION; CONTROLLED STUDY; DATA BASE; DISEASE ACTIVITY; DISEASE COURSE; DISEASE EXACERBATION; DISEASE SEVERITY; GLOMERULONEPHRITIS; HOSPITAL ADMISSION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RACE DIFFERENCE; RETROSPECTIVE STUDY; REVIEW; SOUTHEAST ASIA; SYSTEMIC LUPUS ERYTHEMATOSUS; TERTIARY HEALTH CARE;

EID: 33746524270     PISSN: 02190494     EISSN: 14798077     Source Type: Journal    
DOI: 10.1111/j.1479-8077.2006.00163.x     Document Type: Review

References (24)

1. Uribe AG, Alarcon GS (2003) Ethnic disparities in patients with systemic lupus erythematosus. Curr Rheumatol Rep 5, 364-9.
2. Boey ML, Ng SC, Feng PH (1987) Mortality of Orientals with systemic lupus erythematosus - a reappraisal. Singapore Med J 28, 318-20.
3. Ward MM (2001) Examining health disparities in systemic lupus erythematosus. Arthritis Rheum 44, 2711-4.
4. Barr RG, Seliger S, Appel GB, et al. (2003) Prognosis in proliferative lupus nephritis: The role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 18, 2039-46.
5. Petri M, Perez-Gutthann S, Longenecker JC, et al. (1991) Morbidity of systemic lupus erythematosus: Role of race and socioeconomic status. Am J Med 91, 345-53.
6. Ward MM, Studenski S (1990) Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 150, 849-53.
7. Sirikong M, Tsuchiya N, Chandanayingyong D, et al. (2002) Association of Hla-Drb1*1502-Dqb1*0501 Haplotype with susceptibility to systemic lupus erythematosus in Thais. Tissue Antigens 59, 113-7.
8. Thumboo J, Uramoto K, O'Fallon WM, et al. (2001) A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 45, 494-500.
9. Cooper GS, Parks CG, Treadwell EL, et al. (2002) Differences by race, sex and age in the clinical and immunologic features of recently diagnosed systemic lupus erythematosus patients in the southeastern United States. Lupus 11, 161-7.
10. Seligman VA, Lum RF, Olson JL, et al. (2002) Demographic differences in the development of lupus nephritis: A retrospective analysis. Am J Med 112, 726-9.
11. Serdula MK, Rhoads GG (1979) Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum 22, 328-33.
12. Kaslow RA (1982) High rate of death caused by systemic lupus erythematosus among U.S. residents of Asian descent. Arthritis Rheum 25, 414-8.
13. Edwards CJ, Lian TY, Badsha H, et al. (2003) Hospitalization of individuals with systemic lupus erythematosus: Characteristics and predictors of outcome. Lupus 12, 672-6.
14. Mody GM, Parag KB, Nathoo BC, et al. (1994) High mortality with systemic lupus erythematosus in hospitalized African blacks. Br J Rheumatol 33, 1151-3.
15. Karlson EW, Daltroy LH, Lew RA, et al. (1997) The relationship of socioeconomic status, race, and modifiable risk factors to outcomes in patients with systemic lupus erythematosus. Arthritis Rheum 40, 47-56.
16. Tjam EY (2001) How to find chinese research participants: Use of a phonologically based surname search method. Can J Public Health 92, 138-42.
17. Gladman DD, Urowitz MB, Kagal A, et al. (2000) Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 27, 377-9.
18. Bombardier C, Gladman DD, Urowitz MB, et al. (1992) Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in Sle. Arthritis Rheum 35, 630-40.
19. Arce-Salinas A, Cardiel MH, Guzman J, et al. (1996) Validity of retrospective disease activity assessment in systemic lupus erythematosus. J Rheumatol 23, 846-9.
20. Pons-Estel BA, Catoggio LJ, Cardiel MH, et al. (2004) The Gladel Multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus: Ethnic and disease heterogeneity among 'Hispanics'. Medicine (Baltimore) 83, 1-17.
21. Alarcon GS, McGwin G Jr, Bartolucci AA, et al. (2001) Systemic lupus erythematosus in three ethnic groups. Ix. Differences in damage accrual. Arthritis Rheum 44, 2797-806.
22. Mok CC, Ho CT, Wong RW, et al. (2003) Damage accrual in Southern Chinese patients with systemic lupus erythematosus. J Rheumatol 30, 1513-9.
23. Ibanez D, Gladman DD, Urowitz MB (2005) Adjusted mean systemic lupus erythematosus disease activity index-2k is a predictor of outcome in SLE. J Rheumatol 32, 824-7.
24. Mok CC, Mak A, Chu WP, et al. (2005) Long-term survival of Southern Chinese patients with systemic lupus erythematosus: A prospective study of all age-groups. Medicine (Baltimore) 84, 218-24.